(Q40692423)

aromatic amino acid decarboxylase inhibitors

22 September 2017

title

The Effects of Aromatic Amino Acid Decarboxylase Inhibitors on Plasma Concentrations of 5-Hydroxytryptophan in Man (English)

0 references

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A309271

7 March 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

7 March 2023

author name string

I. Magnussen

1

0 references

F. Engbaek

2

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=309271

7 March 2023

publication date

1 July 1978

1 reference

full work available at URL

22 September 2017

13 March 2009

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0773.1978.tb02229.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0773.1978.tb02229.x/fullpdf

7 March 2023

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Acta pharmacologica et toxicologica

7 March 2023

published in

1 reference

22 September 2017

volume

43

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

36-42

1 reference

5-Hydroxytryptophan: A method for monitoring human plasma content during clinical administration

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Clinical pharmacokinetics of levodopa in parkinson's disease

7 March 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Manipulation of brain serotonin in the treatment of myoclonus

7 March 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Beneficial effects of serotonin precursors in postanoxic action myoclonus

7 March 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent

7 March 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements

7 March 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

The determination of 5-hydroxytryptophan and its metabolites in plasma following administration to man

7 March 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Serum levels of 5-hydroxyindole derivates after administration of L-5-hydroxytryptophan ethyl ester

7 March 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor

7 March 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Anaesthesia for the geriatric patient

7 March 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa

7 March 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition

7 March 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1600-0773.1978.TB02229.X

7 March 2023

Identifiers

0 references

1 reference